Subcutaneous Levodopa in Parkinson's Disease: A Systematic Review and Meta-Analysis
{{output}}
Background: Many Parkinson's disease patients receiving oral levodopa/carbidopa experience a troublesome wearing off effect. Higher doses to mitigate OFF-time are limited by adverse effects occurring at peak dopamine levels, par... ...